Grape King Bio Ltd (TPE:1707)
Taiwan · Delayed Price · Currency is TWD 122.00
-0.50 (-0.41%)
At close: Feb 11, 2026
Grape King Bio Market Cap
Grape King Bio has a market cap or net worth of 18.07 billion as of February 20, 2026. Its market cap has decreased by -16.15% in one year.
Market Cap
18.07B
Enterprise Value
16.53B
Revenue
10.40B
Ranking
n/a
PE Ratio
14.89
Stock Price
122.00
Market Cap Chart
Since February 19, 1992, Grape King Bio's market cap has increased from 2.32B to 18.07B, an increase of 678.15%. That is a compound annual growth rate of 6.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 18.07B | -3.56% |
| Dec 31, 2025 | 18.74B | -15.38% |
| Dec 31, 2024 | 22.15B | -4.17% |
| Dec 29, 2023 | 23.11B | -7.14% |
| Dec 30, 2022 | 24.89B | 5.00% |
| Dec 30, 2021 | 23.70B | -2.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 29.86B |
| TTY Biopharm Company | 20.81B |
| Alar Pharmaceuticals | 17.87B |
| ScinoPharm Taiwan | 17.12B |
| Synmosa Biopharma | 16.25B |
| YungShin Global Holding | 14.73B |
| Foresee Pharmaceuticals | 13.33B |
| Handa Pharmaceuticals | 11.80B |